CG Oncology, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGON and other ETFs, options, and stocks.About CGON
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC).
CEOArthur Kuan
CEOArthur Kuan
Employees113
Employees113
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2010
Founded2010
Employees113
Employees113
CGON Key Statistics
Market cap3.21B
Market cap3.21B
Price-Earnings ratio-20.03
Price-Earnings ratio-20.03
Dividend yield—
Dividend yield—
Average volume764.08K
Average volume764.08K
High today$41.74
High today$41.74
Low today$39.50
Low today$39.50
Open price$41.70
Open price$41.70
Volume926.25K
Volume926.25K
52 Week high$46.01
52 Week high$46.01
52 Week low$14.80
52 Week low$14.80
Stock Snapshot
CG Oncology, Inc.(CGON) stock is priced at $39.75, giving the company a market capitalization of 3.21B. It carries a P/E multiple of -20.03.
As of 2025-12-16, CG Oncology, Inc.(CGON) stock has fluctuated between $39.50 and $41.74. The current price stands at $39.75, placing the stock +0.6% above today's low and -4.8% off the high.
CG Oncology, Inc.(CGON) shares are trading with a volume of 926.25K, against a daily average of 764.08K.
During the past year, CG Oncology, Inc.(CGON) stock moved between $14.80 at its lowest and $46.01 at its peak.
During the past year, CG Oncology, Inc.(CGON) stock moved between $14.80 at its lowest and $46.01 at its peak.
Analyst ratings
100%
of 15 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CGON. This list is generated using Robinhood data, and it’s not a recommendation.